Michael Shah, a Senior Pharma-Biotech Analyst, reveals Novo Nordisk's aggressive pricing strategy for obesity drugs, significantly undercutting Eli Lilly. Liana Baker, Managing Editor for Deals, shares insights on the $6.2 billion acquisition of Sealed Air by Clayton, Dubilier & Rice. Mary Ross Gilbert discusses how retail giants like Ralph Lauren and Gap are poised for a strong sales boost in 2026, while Michael Halen analyzes restaurant trends and how quick-service chains are adapting to rising costs and changing customer preferences.
